That's at least the view of 24/7 Wall St.'s Douglas McIntyre, who lists the Thousand Oaks-based Amgen as among the 10 most undervalued stocks in the U.S. His reasoning: cash flow is running 32 percent of sales. Analysts have been upgrading the stock as antitrust litigation against the company seems to be favoring the biotech company. Earnings in the last quarter beat forecasts. In case you're wondering, the stock is trading at just under $70. Its 52-week high is $81.48; its low is $63.52. (*Perhaps the stock might get a lift through a $5 billion repurchase plan announced Wednesday.) Other names on the undervalued list:

-Gannett (Wall Street hates newspapers, of course, but Gannett has a huge Web presence and it's the sole newspaper in many of its markets).

-eBay

-Sprint

-Hovnanian Enterprises (home builder)

-Alcoa

-Analog Devices

-Washington Post Co. (not for the paper, but for the other stuff it owns, most especially the Kaplan testing company

-Anheuser-Busch

-Linear Technology